Key result
Genetic factors accounted for 62% of the variation in plasma PAF-AH activity, which was also strongly correlated with plasma LDL-C concentrations.
Why the study?
What are the genetic and environmental determinants of plasma PAF-AH activity, and how does it relate to plasma lipoproteins?
Observational (n=240)
What are the genetic and environmental determinants of plasma PAF-AH activity, and how does it relate to plasma lipoproteins?
Plasma PAF-AH activity is highly heritable and strongly correlated with LDL-C levels, suggesting that the rate of LDL removal from circulation may determine PAF-AH clearance.
Answers are grounded in this paper and cite their sources.
Substantial heritability of PAF-AH activity in families; leaves open specific loci and any clinical relevance.
Plasma platelet-activating factor acetylhydrolase (PAF-AH) is the enzyme that inactivates PAF (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine). We determined the relative contributions of genetic and environmental factors to variation in plasma PAF-AH activity in 240 individuals from 60 nuclear families. Regression of mean-offspring PAF-AH activity on the mid-parent value indicated that 62% of the variation in plasma PAF-AH activity was heritable. Spousal values were weakly negatively correlated, indicating that familial aggregation of PAF-AH activity is due to genetic rather than to environmental factors. Among normolipidemic individuals, plasma PAF-AH activity was strongly correlated with the plasma concentration of low density lipoprotein cholesterol (LDL-C), and treatment with lovastatin resulted in proportional decreases in plasma PAF-AH activity and LDL-C concentrations. To further elucidate the relationship between PAF-AH and plasma concentrations of LDL, plasma PAF-AH activity was measured in families with well-defined, monogenic disorders of LDL metabolism. Plasma PAF-AH activity cosegregated with plasma LDL-C concentrations in familial hypercholesterolemia, but not in familial hypobetalipoproteinemia. We speculate that the rate of removal of LDL from the circulation may determine the clearance rate of PAF-AH, thereby modulating the activity of PAF-AH in blood.
No takes yet. Share an insight, caveat, or question.
Guerra et al. (1997) reported an observational. Genetic factors and plasma LDL-C concentrations was evaluated on Variation in plasma PAF-AH activity (62% heritability). Genetic factors accounted for 62% of the variation in plasma PAF-AH activity, which was also strongly correlated with plasma LDL-C concentrations.
Synapse has enriched 10 related papers. Consider them for comparative context: